Description
PLACEBO & ACTIVE IMIQUIMOD
First action · last action
2023-04-28 · 2024-10-31
Transactions
3
First transaction's obligation
$1,261,780
Base + all options value (sum of deltas)
$0
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24E23D0025
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-04-28+$1,261,780= $1,261,780
- Mod P000012023-06-30-$124,998= $1,136,782
- Mod P000022024-10-31-$1,136,782= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-04-28 | +$1,261,780 | $1,261,780 | PLACEBO & ACTIVE IMIQUIMOD |
| Mod P00001· FUNDING ONLY ACTION | 2023-06-30 | −$124,998 | $1,136,782 | PLACEBO & ACTIVE IMIQUIMOD |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2024-10-31 | −$1,136,782 | $0 | PLACEBO & ACTIVE IMIQUIMOD |
Related awards · 8
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI YRPTVKHDL7Z5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24E23D0025 | RPO EAST (36C24E) · AN11 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $0 | FY2023 |
| 36C24E22N0017 | RPO EAST (36C24E) · AN11 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $51,000 | FY2022 |
| 36C24E22D0006 | RPO EAST (36C24E) · AN11 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $0 | FY2022 |
Other recipients under Q517 from RPO EAST (36C24E) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24E20N0147 | LYNN OAKS COMPOUNDING PHARMACY INC. | RPO EAST (36C24E) | $8,176 | FY2020 |
| 36C24E19N0153 | LYNN OAKS COMPOUNDING PHARMACY INC. | RPO EAST (36C24E) | $5,320 | FY2019 |
| 36C24E19N0082 | JRS PHARMA LP | RPO EAST (36C24E) | $8,282 | FY2019 |
| 36C24E18N0063 | LYNN OAKS COMPOUNDING PHARMACY INC. | RPO EAST (36C24E) | $13,110 | FY2018 |
| 36C24E18D0055 | LYNN OAKS COMPOUNDING PHARMACY INC. | RPO EAST (36C24E) | $0 | FY2018 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24E23N0099_3600_36C24E23D0025_3600 · retrieved 2026-09-27.